We were delighted to host Cancer52 member organisations in our offices today. An opportunity for insightful conversations on how to maximise the impact of genomics in rare conditions and cancer through collaboration.
Delighted to be part of today’s roundtable event hosted by Genomics England, alongside Cancer52 charity member organisations. We’re here to explore collaborative opportunities and look into how whole genome sequencing (WGS) data can be used to maximise the impact of genomics for rare and less common cancers patients - to benefit from early detection, accessing best treatments, and contributing to research for improved future treatment options. Our thanks to Tessa Jowell Brain Cancer Mission and Sarcoma UK for presenting. #cancer #genomics #rarecancer #cancerresearch #cancercharity #collaboration
Can’t wait to hear results of discussions. These conversations are so important.
It’s inspiring to see such collaboration between Cancer52 member organisations and Genomics England, working together to harness the power of genomics. The potential for whole genome sequencing to transform early detection and treatment for rare cancers is immense, and these discussions will undoubtedly lead to more impactful research and better outcomes for patients. Looking forward to seeing how this develops! #CancerResearch #Genomics #Collaboration #RareCancers